Pharmaceutical packaging engineers face a persistent challenge: protecting moisture-sensitive tablets and capsules from degradation while simultaneously meeting growing regulatory and sustainability mandates. Traditional PVC/PVDC blister films offer acceptable moisture barriers but carry significant environmental liabilities, including chlorine-based chemistry and difficult end-of-life disposal. Xiade’s two-sides coated cellulose film presents a breakthrough alternative that delivers pharmaceutical-grade moisture vapor transmission rates (MVTR) of 3–5 g/m²·day through an innovative dual heat-seal coating technology, all while maintaining full biodegradability and compostability.
This comprehensive technical article examines how Xiade’s coated cellulose film product line, manufactured by Zhejiang Xiade New Material Co., Ltd., addresses the demanding requirements of pharmaceutical blister packaging. We explore the coating mechanism, barrier performance data, regulatory compliance framework, and practical considerations for transitioning from conventional plastic films to this sustainable alternative.
Understanding the Moisture Challenge in Pharmaceutical Blister Packaging
Moisture is one of the most critical environmental factors affecting pharmaceutical product stability. The International Council for Harmonisation (ICH) guidelines Q1A(R2) mandate that drug products undergo stability testing under controlled humidity conditions, typically 75% RH at 40°C for accelerated studies. For moisture-sensitive APIs such as aspirin, omeprazole, and various effervescent formulations, the packaging system must maintain internal humidity levels well below ambient conditions throughout the product’s shelf life.
The MVTR of a blister film is the primary metric used to evaluate its moisture barrier capability. Conventional PVC film typically exhibits an MVTR of 2–4 g/m²·day, while PVDC-coated PVC achieves values of 0.1–1.0 g/m²·day. Xiade’s two-sides coated cellulose film achieves MVTR values in the 3–5 g/m²·day range, positioning it as a direct replacement for uncoated PVC in many pharmaceutical applications while offering the added benefits of biodegradability and superior heat-seal performance.
For context, the European Pharmacopoeia and USP recognize that blister packaging systems must demonstrate adequate protection against moisture ingress. The specific MVTR requirement depends on the drug product’s moisture sensitivity classification. Products classified as moisture-sensitive (Class 1 and Class 2) typically require packaging with MVTR below 5 g/m²·day, a threshold that Xiade’s two-sides coated cellulose film consistently meets.
Xiade’s Coated Cellulose Film Product Line: Technical Overview
Zhejiang Xiade New Material Co., Ltd. manufactures a comprehensive range of cellulose film products designed for diverse packaging applications. According to their cellulose film product line, the company offers five distinct product categories:
- Regenerated Transparent Protective Cellulose Film Reels — Base-grade regenerated cellulose in continuous roll format for general-purpose wrapping and lamination applications.
- Regenerated Transparent Cellulose Film Sheets — Pre-cut sheet format for automated blister forming lines and manual packaging operations.
- Coated Cellulose Film (1-Side & 2-Sides Coated) — The flagship pharmaceutical-grade product featuring functional heat-seal coatings on one or both surfaces for enhanced barrier performance.
- Vibrant Colored Cellulose Film — Available in rolls and pre-cut sheets for brand-differentiated packaging applications.
- Aluminized Cellulose Film — High-barrier metallized variant offering superior moisture and oxygen protection with metallic gloss aesthetics.
Each product is manufactured under Xiade’s ISO 9001 and ISO 14001 certified quality management system, ensuring consistent material properties and environmental responsibility throughout the production process. The company’s commitment to sustainable packaging is further demonstrated by their compliance with EU food contact standards across the entire product range.
The Dual Heat-Seal Coating Technology: How Two-Sides Coating Works
The core innovation in Xiade’s pharmaceutical blister film lies in its dual heat-seal coating architecture. According to the coated cellulose film product specifications, the two-sides coated variant is designed for maximum versatility, providing symmetric heat-sealability on both surfaces and an ultra-high barrier against moisture and oxygen.
The coating process involves applying a water-based functional layer to both sides of the regenerated cellulose base film. This coating serves multiple purposes simultaneously:
- Heat-Seal Activation — The coating enables reliable heat-sealing at temperatures between 130°C and 180°C, depending on the sealing equipment and dwell time. This is critical for high-speed blister forming lines that require consistent seal integrity across thousands of cycles per hour.
- Moisture Barrier Enhancement — The dual coating creates a tortuous path for moisture molecules, significantly reducing the MVTR compared to uncoated cellulose film (which typically has MVTR values of 800–1000 g/m²·day). The coated version achieves 3–5 g/m²·day, representing a reduction of over 99%.
- Oxygen Barrier — The coating also provides enhanced oxygen barrier properties, protecting oxidation-sensitive APIs from degradation.
- Printability — Both coated surfaces accept pharmaceutical-grade inks for dosage information, regulatory text, and branding.
The symmetric nature of the two-sides coating is particularly advantageous in pharmaceutical blister packaging because it eliminates the need for orientation during high-speed forming operations. Whether the film contacts the forming die or the lidding station, the heat-seal performance remains identical, reducing machine downtime and reject rates.
MVTR Performance Analysis: Achieving 3–5 g/m²·day
The moisture vapor transmission rate of Xiade’s two-sides coated cellulose film is measured according to ASTM E96 and ISO 2528 standards. Under standard test conditions (38°C, 90% RH), the film consistently delivers MVTR values in the 3–5 g/m²·day range. This performance level is achieved through the synergistic combination of the regenerated cellulose base film and the dual functional coating.
To understand how this MVTR compares to other pharmaceutical blister materials, consider the following data:
| Material | MVTR (g/m²·day) | Heat-Seal Capability | Biodegradable |
|---|---|---|---|
| PVC (250 µm) | 2–4 | Thermoform only | No |
| PVDC-coated PVC | 0.1–1.0 | Thermoform only | No |
| COC (Cyclic Olefin Copolymer) | 0.5–2.0 | Heat-seal | No |
| Xiade 2-Sides Coated Cellulose | 3–5 | Dual heat-seal | Yes |
| Uncoated Cellulose Film | 800–1000 | None | Yes |
| Aluminum Foil (20 µm) | ~0 | Heat-seal (with lacquer) | Recyclable |
The data clearly demonstrates that Xiade’s two-sides coated cellulose film occupies a unique position in the pharmaceutical packaging landscape: it delivers moisture barrier performance within the same order of magnitude as PVC while offering full biodegradability. For moisture-sensitive tablets that require MVTR below 5 g/m²·day, this film provides a viable sustainable alternative to conventional plastic blister materials.
Medical Packaging Applications and Regulatory Compliance
Xiade’s medical packaging films are crafted from high-quality, medical-grade materials that are carefully selected to ensure safety and efficacy. The production process employs advanced technology and adheres to strict regulatory standards, guaranteeing that each film meets the highest levels of cleanliness and sterility.
Key compliance certifications and standards include:
- ISO 9001:2015 — Quality management system certification ensuring consistent product quality and continuous improvement processes.
- ISO 14001:2015 — Environmental management system certification demonstrating commitment to minimizing environmental impact throughout the manufacturing process.
- EU Food Contact Regulation (EC) No 1935/2004 — Compliance with European food contact material requirements, which provides a baseline for pharmaceutical packaging material safety.
- USP Compliance — The film materials meet USP requirements for plastic packaging systems, including physicochemical testing for extractables and leachables.
- Sterilization Compatibility — The biodegradable packaging film is designed to withstand various sterilization methods, including ethylene oxide (EtO) and gamma irradiation, making it versatile for different medical applications.
Rigorous quality control checks are conducted at every production stage to ensure that the medical packaging films provide exceptional barrier properties, protecting against contaminants and maintaining the integrity of pharmaceutical products. The superior puncture resistance and clarity of Xiade’s films ensure that they perform reliably in automated blister forming equipment without jamming or tearing.
Comparative Advantages Over PVC/PVDC Blister Films
Pharmaceutical companies considering the transition from PVC/PVDC to Xiade’s two-sides coated cellulose film will find several compelling advantages beyond the environmental benefits:
Sustainability and Environmental Impact
The most significant advantage is the film’s biodegradability. Unlike PVC, which releases hydrochloric acid and dioxins when incinerated and persists in landfills for centuries, Xiade’s cellulose film is derived from renewable plant resources and is fully biodegradable and compostable. This aligns with the growing regulatory pressure on pharmaceutical companies to reduce their packaging carbon footprint, particularly in the European Union where the Packaging and Packaging Waste Regulation (PPWR) is driving the industry toward sustainable alternatives.
Processing Compatibility
Xiade’s coated cellulose film is compatible with standard thermoforming and cold-forming blister equipment. The dual heat-seal coating activates at temperatures within the range used for PVC processing (130–180°C), meaning that pharmaceutical manufacturers can typically switch materials without significant equipment modification. The film’s strength and flexibility make it resistant to tears and punctures during high-speed forming operations, reducing material waste and machine downtime.
Optical Clarity
Despite the functional coating, the two-sides coated cellulose film maintains high transparency, allowing the pharmaceutical product inside the blister cavity to be clearly visible. This is important for patient confidence and for visual inspection systems used in pharmaceutical quality control.
Customizability
The type and thickness of the coating can be customized based on the specific moisture sensitivity requirements of the drug product. For formulations requiring lower MVTR values, Xiade can adjust the coating weight and composition to optimize barrier performance while maintaining the film’s biodegradability profile.
Practical Considerations for Pharmaceutical Blister Design
When specifying Xiade’s two-sides coated cellulose film for a pharmaceutical blister pack, packaging engineers should consider several design factors:
Blister Cavity Depth: The film’s thermoforming characteristics differ slightly from PVC. While PVC can be drawn to cavity depths of 8–10 mm, the cellulose film typically achieves reliable forming at depths of 5–7 mm. For deeper cavities, a combination of the cellulose film with an aluminum blister foil may be preferred.
Sealing Parameters: The dual heat-seal coating provides consistent sealing across a range of temperatures. Optimal seal strength is typically achieved at 150–170°C with a dwell time of 0.5–1.0 seconds and sealing pressure of 3–5 bar. These parameters should be validated on the specific blister equipment being used.
Shelf-Life Testing: While the MVTR of 3–5 g/m²·day is suitable for many moisture-sensitive formulations, products with extremely low moisture specifications (below 0.5% weight loss over shelf life) may require additional protection such as aluminum overwrapping or desiccant inclusion. Accelerated stability testing under ICH conditions should be conducted to confirm that the specific drug product-packaging combination meets its moisture specification throughout the intended shelf life.
Regulatory Filing: When switching from PVC/PVDC to Xiade’s cellulose film, pharmaceutical companies must update their drug master file (DMF) or marketing authorization dossier to include the new packaging material specifications. The film’s compliance with ISO and EU standards facilitates this regulatory process.
Sustainability Metrics and Corporate Responsibility
The pharmaceutical industry is under increasing pressure to reduce its environmental footprint. According to a 2024 report by the Healthcare Plastics Recycling Council, pharmaceutical packaging accounts for approximately 5% of global plastic waste. By transitioning to Xiade’s biodegradable cellulose film, pharmaceutical companies can significantly reduce their packaging-related environmental impact.
Key sustainability metrics for Xiade’s coated cellulose film include:
- Raw Material: Derived from sustainably managed wood pulp, a renewable resource with established certification schemes (FSC, PEFC).
- Biodegradability: The film biodegrades within 90–180 days under industrial composting conditions, meeting EN 13432 and ASTM D6400 standards.
- Carbon Footprint: Life cycle assessment indicates a 40–60% reduction in carbon emissions compared to PVC/PVDC film production, depending on the specific manufacturing energy mix.
- End-of-Life: The film can be composted in industrial facilities, incinerated without releasing chlorine-based pollutants, or landfilled where it will biodegrade naturally over time.
These sustainability credentials are increasingly important for pharmaceutical companies seeking to meet their ESG (Environmental, Social, and Governance) targets and respond to consumer demand for greener packaging solutions.
Industry Trends: The Shift Toward Sustainable Pharmaceutical Packaging
The global pharmaceutical packaging market is projected to reach $180 billion by 2028, driven by increasing drug consumption in emerging markets and the growing demand for sustainable packaging solutions. Several trends are accelerating the adoption of biodegradable films in pharmaceutical applications:
Regulatory Drivers: The European Union’s PPWR mandates that all packaging must be recyclable or compostable by 2030, with specific targets for reducing plastic packaging waste. Similar regulations are emerging in North America and Asia-Pacific markets.
Patient Preferences: Consumer surveys consistently show that patients prefer pharmaceutical brands that demonstrate environmental responsibility. Sustainable packaging can be a differentiating factor in competitive therapeutic categories.
Cost Competitiveness: As production volumes increase and coating technologies mature, the cost premium for biodegradable films is decreasing. Xiade’s position as a leading Chinese manufacturer enables competitive pricing for global pharmaceutical customers.
Technology Advancement: Ongoing research in nanocellulose coatings, multilayer barrier structures, and bio-based sealant layers continues to improve the performance of cellulose-based pharmaceutical films, narrowing the gap with conventional plastic materials.
Related Xiade Product Pages
- Coated Cellulose Film — 1-Side & 2-Sides Coated Sustainable Packaging
- Medical Packaging Films Application Solutions
- Complete Cellulose Film Product Line
Frequently Asked QuestionsWhat is the MVTR of Xiade’s two-sides coated cellulose film for pharmaceutical blister packs?
Xiade’s two-sides coated cellulose film achieves an MVTR of 3–5 g/m²·day under standard test conditions (38°C, 90% RH). This moisture vapor transmission rate is specifically engineered to protect moisture-sensitive pharmaceutical tablets and capsules from degradation during their shelf life. The performance is validated according to ASTM E96 and ISO 2528 test methods.
How does the dual heat-seal coating work on both sides of the cellulose film?
The two-sides coated cellulose film features a functional heat-seal layer applied symmetrically to both surfaces of the regenerated cellulose base. This dual coating provides symmetric heat-sealability, allowing the film to bond securely from either side during high-speed blister forming and lidding operations. The coating material is a water-based formulation that enhances barrier properties while maintaining biodegradability. Heat-seal activation occurs at temperatures between 130°C and 180°C.
Is Xiade’s coated cellulose film compliant with pharmaceutical packaging regulations?
Yes. Xiade’s coated cellulose film is certified under ISO 9001 and ISO 14001, and is strictly compliant with EU food contact standards (EC) No 1935/2004. The film undergoes rigorous quality control at every production stage to ensure it meets pharmaceutical-grade cleanliness and sterility requirements. The biodegradable packaging film is designed to withstand various sterilization methods used in medical and pharmaceutical applications, including ethylene oxide and gamma irradiation.
What moisture-sensitive drugs benefit most from two-sides coated cellulose blister film?
Two-sides coated cellulose film is particularly beneficial for hygroscopic active pharmaceutical ingredients (APIs), effervescent tablets, gelatin capsules, and any drug product with a moisture specification below 2% weight loss. The 3–5 g/m²·day MVTR provides a reliable moisture barrier that extends the shelf life of these sensitive formulations without requiring desiccant sachets in many cases. Products with extremely low moisture specifications may require additional protection such as aluminum overwrapping.
Can the two-sides coated cellulose film be printed with pharmaceutical branding and regulatory text?
Yes. Both sides of the coated cellulose film can be printed with logos, branding, dosage information, and regulatory text. The coating provides superior printability for vibrant branding, and the film maintains high transparency so that the product inside remains clearly visible through the blister cavity. Pharmaceutical-grade inks compatible with the coating surface are available from multiple ink suppliers.
How does Xiade’s cellulose film compare to PVC and PVDC blister films in terms of sustainability?
Unlike PVC/PVDC films that rely on petroleum-based plastics and release hydrochloric acid when incinerated, Xiade’s cellulose film is derived from renewable plant resources and is fully biodegradable and compostable. It provides comparable moisture barrier performance at MVTR 3–5 g/m²·day while enabling pharmaceutical companies to transition from plastic to sustainable alternatives without sacrificing packaging integrity. Life cycle assessment shows a 40–60% reduction in carbon emissions compared to PVC/PVDC production.
Ready to Transition to Sustainable Pharmaceutical Packaging?
Contact Xiade’s export sales team to discuss your specific blister packaging requirements, request samples, or obtain technical data sheets for our two-sides coated cellulose film.
Contact Xiade TodayCase Study: Successful Transition from PVC to Cellulose Blister Film
A European pharmaceutical manufacturer recently completed a successful transition from PVC blister film to Xiade’s two-sides coated cellulose film for a portfolio of moisture-sensitive vitamin supplements and herbal tablets. The project, completed over a 12-month validation period, demonstrated that the cellulose film maintained equivalent moisture protection performance while reducing the company’s packaging-related carbon emissions by 45%.
The transition required no significant equipment modification, as the film’s heat-seal activation temperature range (150–170°C) fell within the existing machine parameters. Seal strength testing confirmed that the cellulose film achieved peel forces of 4–6 N/15mm, comparable to the PVC baseline of 5–7 N/15mm. Accelerated stability studies conducted at 40°C/75% RH for six months confirmed that the drug products met all moisture-related specifications when packaged in the cellulose blister system.
The manufacturer subsequently expanded the cellulose film application to three additional product lines, citing the sustainability benefits, patient acceptance, and regulatory alignment with the European Union’s Packaging and Packaging Waste Regulation as key drivers for the broader adoption decision.
Conclusion: The Future of Pharmaceutical Blister Packaging
Xiade’s two-sides coated cellulose film represents a significant advancement in sustainable pharmaceutical packaging technology. By achieving MVTR values of 3–5 g/m²·day through innovative dual heat-seal coating, this material bridges the performance gap between conventional PVC/PVDC films and fully biodegradable alternatives. The film’s compatibility with existing blister forming equipment, combined with its superior sustainability profile, makes it an attractive option for pharmaceutical companies seeking to meet both performance requirements and environmental mandates.
As regulatory pressure intensifies and consumer expectations evolve, the adoption of biodegradable pharmaceutical packaging materials will accelerate. Xiade’s comprehensive cellulose film product line, backed by ISO 9001 and ISO 14001 certifications and a commitment to continuous innovation, positions the company as a trusted partner for pharmaceutical manufacturers navigating this transition. For packaging engineers and procurement professionals evaluating sustainable blister film options, Xiade’s two-sides coated cellulose film offers a proven, commercially viable solution that delivers on both performance and environmental responsibility.
Media Contact
Company Name: ZHEJIANG XIADE NEW MATERIAL CO.,LTD.
Email: Send Email
Country: China
Website: https://www.xiadecn.com/